The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chemomobilization with (R)-ICE (rituximab, ifosfamide, carboplatin, etoposide) compared to G-CSF and plerixafor (G+P) mobilization in lymphoid malignancies.
 
Lauren Westfall Veltri
No Relationships to Disclose
 
Binod Dhakal
No Relationships to Disclose
 
Arun K. Singavi
No Relationships to Disclose
 
Sijin Wen
No Relationships to Disclose
 
Jin Luo
No Relationships to Disclose
 
Michael D. Craig
No Relationships to Disclose
 
Aaron Cumpston
No Relationships to Disclose
 
Alexandra Shillingburg
No Relationships to Disclose
 
Kathy Watkins
No Relationships to Disclose
 
Jean Esselman
No Relationships to Disclose
 
Marcelo C. Pasquini
No Relationships to Disclose
 
Timothy S. Fenske
No Relationships to Disclose
 
Parameswaran Hari
Stock and Other Ownership Interests - Pharmacyclics
Honoraria - Celgene; Millennium; Onyx; Sanofi
Consulting or Advisory Role - Celgene; Millennium; Onyx; Sanofi
Research Funding - Celgene (Inst); Millennium (Inst)
 
Mehdi Hamadani
Honoraria - Celgene
Consulting or Advisory Role - Celerant; MedImmune
Research Funding - Takeda
 
Abraham Sebastian Kanate
No Relationships to Disclose